Supercentenarian

Longevity Insights

February 2026

Research Breakthroughs

Human research that changes how we think about aging and health.

FDA clears first human trial of epigenetic reprogramming therapy

The FDA has cleared the first-ever human trial of an epigenetic reprogramming therapy—the approach based on Yamanaka's Nobel Prize-winning discovery that cells can be coaxed back to a younger state. The trial will focus on eye disease, a logical starting point given the eye's accessibility and the desperate need for new treatments. We're years from knowing if this works in humans, but the regulatory green light marks a genuine turning point.

Immunis reports interim Phase 2 results for secretome biologic in obese sarcopenic seniors

In a double-blind, placebo-controlled Phase 2 trial, older adults with obesity and muscle loss who received IMM01-STEM—a secretome biologic derived from stem cells—showed clinically meaningful improvements in physical function. What makes this notable: participants improved mobility while losing weight, a combination that's proven remarkably difficult to achieve in this population. The therapy appears to work by delivering regenerative signals without the cells themselves.

This discovery could let bones benefit from exercise without moving

Researchers identified a protein that acts as a mechanical sensor in bone marrow stem cells, detecting physical activity and directing those cells to build bone rather than store fat. The discovery explains a key mechanism behind exercise's bone-building benefits and opens the door to treatments that could mimic this signal. The work involved human cells and could eventually help those who can't exercise maintain bone density.

Lifestyle & Movement

What the evidence says about how we move, sleep, and live.

MRI scans show exercise can make the brain look younger

Using MRI scans, researchers found that midlife adults who maintained consistent aerobic exercise for a year showed brains that appeared nearly a year younger than those who didn't change their habits. The study measured actual structural changes in brain tissue, not just cognitive test scores. This adds to the mounting evidence that cardio isn't just good for your heart—it's measurably protective for your brain.

Exercise Reduces Immunosenescence

An observational study in older adults found that regular exercisers showed reduced chronic inflammatory signaling and enhanced immune competency compared to their sedentary peers. The effect appears to counteract immunosenescence—the gradual decline in immune function that makes older adults more vulnerable to infections and less responsive to vaccines. Exercise, it seems, keeps the immune system acting younger.

Real-time data links sleep quality to brain aging

Researchers used real-time brain imaging (MEG scans) to observe how disrupted sleep affects brain activity in adults. Poor sleep quality was associated with altered brain activity patterns that resemble those seen in older brains. The study provides direct evidence for the mechanism connecting sleep problems to accelerated brain aging.

Nutrition & Diet

What we're learning about food, fasting, and the microbiome.

Changes in the Gut Microbiome are Associated with Mild Cognitive Impairment

An observational study found that people with mild cognitive impairment—the stage that often precedes Alzheimer's—had distinctly different gut microbiome profiles, with a shift toward more inflammatory bacterial species. The finding supports the growing "gut-brain axis" hypothesis and suggests the microbiome might be both a marker and potential intervention target for cognitive decline.

Tea can improve your health and longevity, but how you drink it matters

A large observational study confirmed that regular tea consumption—especially green tea—is associated with better heart health, improved metabolism, and lower risks of diabetes and cancer. The catch: these benefits appear linked to freshly brewed tea, not the sweetened, processed versions that dominate store shelves. How you drink your tea matters as much as whether you drink it.

Newly discovered coffee compounds beat diabetes drug in lab tests

In laboratory tests, researchers identified new compounds in roasted coffee that inhibit α-glucosidase—an enzyme involved in blood sugar regulation—more potently than acarbose, a common diabetes medication. This is cell-based research, not a clinical trial, but it adds mechanistic support to the epidemiological evidence linking coffee consumption to better metabolic health.

From the Lab

Early-stage research that hints at where the science is heading—promising, but years from your medicine cabinet.

Stanford scientists found a way to regrow cartilage and stop arthritis

Stanford researchers found that blocking a protein called 15-PGDH reversed cartilage loss in aged mice and injured joints, restoring healthy cartilage and improving joint function. They validated the finding using human cartilage samples from knee replacement surgeries, showing the same pathway is active in human tissue. If this translates to clinical trials, it could represent a genuine treatment for arthritis rather than just symptom management.

Study shows young blood can slow Alzheimer’s in mice

When old mice were surgically connected to young mice (sharing blood circulation), their memory improved and Alzheimer's-related protein buildup decreased. The reverse was also true: young mice exposed to old blood showed worsened memory and increased toxic proteins. The study reinforces that something in blood changes with age—and that these changes are potentially reversible.

Fecal Microbiota Transplantation from Young Mice to Old Mice Improves Intestinal Stem Cell Function

Transplanting gut bacteria from young mice into old mice improved the function of intestinal stem cells, suggesting the microbiome directly influences tissue regeneration capacity. The effect wasn't subtle—the old mice's intestinal lining showed measurably improved renewal. This adds to evidence that the microbiome is a potential lever for addressing age-related tissue decline.

Intervene Immune puts thymus regeneration back in the spotlight

UCSF researchers found that silencing a single transcription factor using siRNA rejuvenated human cells in culture without triggering the problematic pathways that have plagued previous reprogramming attempts. The approach is more targeted than Yamanaka factor-based reprogramming, potentially offering a cleaner route to cellular rejuvenation. It's early days, but the precision is encouraging.

Supercentenarian

This newsletter is for informational purposes only and does not constitute medical advice. The research summarized here is intended to inform, not prescribe. Always consult qualified healthcare professionals before making decisions about your health.